Terms: = Cervical cancer AND MLLT3, AF9, 4300, ENSG00000171843, P42568, YEATS3, AF-9
6 results:
1. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ.
Liu J; Wang Y; Wan X; Zou J; Zhu Y; Lv W; Shen Y
J Gynecol Oncol; 2023 Jan; 34(1):e8. PubMed ID: 36424703
[TBL] [Abstract] [Full Text] [Related]
3. Follow-up of women screened for cervical cancer in São Paulo, Brazil: An analysis of the times to diagnostic investigation and treatment.
Madalena Ribeiro C; Dos Santos Silva I; Eluf Neto J; Pereira Baltar Cury LC; Azevedo E Silva G
Cancer Epidemiol; 2021 Jun; 72():101940. PubMed ID: 33906100
[TBL] [Abstract] [Full Text] [Related]
4. The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment.
Qendri V; Bogaards JA; Baussano I; Lazzarato F; Vänskä S; Berkhof J
Lancet Public Health; 2020 Nov; 5(11):e592-e603. PubMed ID: 33120045
[TBL] [Abstract] [Full Text] [Related]
5. Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States.
Brisson M; Laprise JF; Chesson HW; Drolet M; Malagón T; Boily MC; Markowitz LE
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26438574
[TBL] [Abstract] [Full Text] [Related]
6. Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches.
Taylor DC; Pawar V; Kruzikas DT; Gilmore KE; Sanon M; Weinstein MC
Pharmacoeconomics; 2012 Feb; 30(2):119-26. PubMed ID: 22149631
[TBL] [Abstract] [Full Text] [Related]
